Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/1/2025

Benzodiazepine Withdrawal-Related Tinnitus Management

Taper Adjustment

  • For patients on long-term benzodiazepines (≥1 year), tapers of 10% per month or slower are better tolerated than rapid tapers, as recommended by the Centers for Disease Control and Prevention (CDC) and the Mayo Clinic 1, 2
  • The appearance of clinically significant withdrawal symptoms like tinnitus signals the need to further slow the taper rate, according to the CDC 1

Evidence-Based Tapering Protocol

  • Each new dose should be 90% of the previous dose, not a straight-line reduction, as suggested by the Mayo Clinic 3
  • The taper may require several months to years depending on individual tolerance, as noted by the CDC and the Mayo Clinic 1, 2

Symptomatic Management

  • Consider gabapentin for short-term use to mitigate anxiety and irritability associated with withdrawal, as recommended by the Mayo Clinic 4, 5, 6
  • Trazodone (25-50 mg at bedtime) can help with insomnia and anxiety without adding another benzodiazepine, according to the Mayo Clinic 4, 5, 6

Critical Monitoring

  • Follow up at least monthly, preferably more frequently during this symptomatic period, as recommended by the CDC 1
  • Monitor for other protracted withdrawal symptoms: dysphoria, irritability, insomnia, anhedonia, anxiety, as suggested by the Mayo Clinic 7, 8

Patient Communication

  • Reassure the patient that slowing or pausing the taper is not failure but rather appropriate medical management, as noted by the CDC and the Mayo Clinic 1, 3